Travere Therapeutics, Inc. , a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases.
Travere Therapeutics stock last closed at $27.76, down 0.96% from the previous day, and has increased 33.01% in one year. It has overperformed other stocks in the Biotechnology industry by 0.6 percentage points. Travere Therapeutics stock is currently +115.03% from its 52-week low of $12.91, and -34.11% from its 52-week high of $42.13.
There are currently 92.24M TVTX shares outstanding. The market capitalization of TVTX is $2.56B. In the last 24 hours, 666,000 TVTX shares were traded.
How to Buy Travere Therapeutics Stock
Wondering how to invest in Travere Therapeutics stock? Here's how.
Choose where to buy Travere Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you figure out where to buy Travere Therapeutics stock.
Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Deposit funds into your investment account: Pick your method of payment and add your info.
Evaluate Travere Therapeutics stock: The Travere Therapeutics ticker symbol is TVTX. Is Travere Therapeutics stock a good investment? Should you buy shares of TVTX? How do TVTX's underlying business fundamentals look? Do top analysts think Travere Therapeutics is a good buy? Why has TVTX's stock price moved recently? (Hint: Our stock market analysis website can help you decide if TVTX is a good stock to buy).
Place your TVTX buy order: Decide if you will purchase TVTX shares at the current market price or use a limit order to buy TVTX shares at a specific price.
Watch your investment in TVTX: Create a watchlist to watch your investment in Travere Therapeutics shares.
Step 1: Choose where to buy Travere Therapeutics stock
You need an online brokerage account to access the NASDAQ market and buy TVTX shares.
A brokerage account is an investment account that allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. Here's why:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to world markets: From Tech to Real Estate, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal information so you can invest in TVTX stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Travere Therapeutics stock
After you have figured out the best place to buy Travere Therapeutics stock, it's very important to evaluate their stock prior to investing, so you truly wrap your head around the risk and upside.
Travere Therapeutics stock data
TVTX Price
$27.76
1w %
-3.04%
1y %
33.01%
5y %
-0.32%
P/E
-95.72x
P/B
22.3x
P/S
5.05x
PEG
N/A
Revenue
$490.73M
Earnings
-$25.55M
Fore. Rev. Growth
31.65%
Fore. Earn. Growth
N/A
Market Cap
$2.56B
Next Earnings
Apr 30, 2026
Next Dividend
N/A
TVTX Due Diligence Checks
WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis in less time.
Last year, TVTX revenue was $490.73M. During the past five year, TVTX's revenue has increased by 19.87% per year. This was slower than the Biotechnology industry average of 28.23%.
No, Travere Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about TVTX
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Place your TVTX buy order
There are two main options:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are generally the easiest way to buy.
Limit order: A limit order is an order to buy or sell a stock at a specific price (or better). If you want to be certain you're buying or selling at a given price limit, place a limit order.
Hit the Open Trade button and eToro will place the order.
If you want more help with investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Travere Therapeutics share?
As of Mar 17, 2026, it costs $27.76 to buy one share of Travere Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.36 shares of TVTX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.